These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
137 related items for PubMed ID: 2036658
1. Potentiation of the efficacy of murine L1210 leukemia vaccine by a novel immunostimulator 7-thia-8-oxoguanosine: increased survival after immunization with vaccine plus 7-thia-8-oxoguanosine. Sharma BS, Balazs L, Jin A, Wang JC, Jolley WB, Robins RK. Cancer Immunol Immunother; 1991; 33(2):109-14. PubMed ID: 2036658 [Abstract] [Full Text] [Related]
2. Immunomodulatory activity of a novel nucleoside, 7-thia-8-oxoguanosine: I. Activation of natural killer cells in mice. Sharma BS, Mhaskar S, Balazs L, Siaw M. Immunopharmacol Immunotoxicol; 1992; 14(1-2):1-19. PubMed ID: 1597650 [Abstract] [Full Text] [Related]
3. Immunomodulatory activity of a novel nucleoside, 7-thia-8-oxoguanosine. II. Characterization of induced effector cells and the mechanism of induction. Sharma BS, Mhaskar S, Balazs L, Jin A, Smee DF. Immunopharmacol Immunotoxicol; 1992; 14(1-2):21-38. PubMed ID: 1375956 [Abstract] [Full Text] [Related]
4. Successful immunotherapy of murine melanoma metastases with 7-thia-8-oxoguanosine. Sharma BS, Balazs L, Jin A, Jolley WB, Robins RK. Clin Exp Metastasis; 1991; 9(5):429-39. PubMed ID: 1914279 [Abstract] [Full Text] [Related]
5. Production of antitumor T-cells in tumor-bearing mice treated with tumor vaccine and 6-mercaptopurine. Kataoka T, Oh-hashi F. Cancer Res; 1985 Jul; 45(7):2962-6. PubMed ID: 3873988 [Abstract] [Full Text] [Related]
6. Synergistic effects of Actinobacillus suis cells in combination with 5-fluorouracil on mice bearing murine L1210 leukemia cells. Watanabe T, Itoh S. Cancer Immunol Immunother; 1997 Jun; 44(4):216-20. PubMed ID: 9222280 [Abstract] [Full Text] [Related]
7. Therapeutic effectiveness of neuraminidase-treated tumor cells as an immunogen in man and experimental animals with leukemia. Bekesi JG, Roboz JP, Holland JF. Ann N Y Acad Sci; 1976 Jun; 277(00):313-31. PubMed ID: 1069551 [Abstract] [Full Text] [Related]
8. In vivo potentiation of concanavalin A-bound L1210 vaccine by antimacrophage agents. Kataoka T, Oh-hashi F, Sakurai Y, Gomi K. Cancer Res; 1980 Oct; 40(10):3832-8. PubMed ID: 6254642 [Abstract] [Full Text] [Related]
9. A novel guanosine analog, 7-thia-8-oxoguanosine, enhances macrophage and lymphocyte antibody-dependent cell-mediated cytotoxicity. Jin A, Mhaskar S, Jolley WB, Robins RK, Ojo-Amaize EA. Cell Immunol; 1990 Apr 01; 126(2):414-9. PubMed ID: 2311125 [Abstract] [Full Text] [Related]
10. Immunotherapeutic response of concanavalin A-bound L1210 vaccine enhanced by a streptococcal immunopotentiator, OK-432. Kataoka T, Oh-hashi F, Sakurai Y. Cancer Res; 1979 Jul 01; 39(7 Pt 1):2807-10. PubMed ID: 445486 [Abstract] [Full Text] [Related]
11. Immunogenicity and amplifier cell production by tumor vaccines enhanced by concanavalin A. Kataoka T, Oh-Hashi F, Sakurai Y. Gan; 1982 Apr 01; 73(2):193-205. PubMed ID: 6811360 [Abstract] [Full Text] [Related]
12. Recovery of the ability to induce immune resistance against L1210 lymphatic leukemia in semisyngeneic CD2F1 mice after lethal irradiation and reconstitution with bone marrow purged of leukemia with mafosfamide (ASTA Z 7654). Skórski T, Kawalec M. Bone Marrow Transplant; 1987 Dec 01; 2(4):435-40. PubMed ID: 3332191 [Abstract] [Full Text] [Related]
13. Effect of forphenicinol on the production of Ia-positive macrophages in mice with or without L1210 leukemia and on the growth of L1210 in immunized mice. Okura A, Arakawa H, Yoshinari T, Naito K, Ishizuka M, Takeuchi T, Umezawa H. J Antibiot (Tokyo); 1986 Apr 01; 39(4):575-80. PubMed ID: 3458691 [Abstract] [Full Text] [Related]
14. Blastogenic potency of concanavalin-A-bound L1210 leukemic vaccine associated with its immunogenic activity. Kataoka T, Oh-hashi F, Sakurai Y. Gan; 1979 Apr 01; 70(2):155-64. PubMed ID: 111995 [Abstract] [Full Text] [Related]
15. Immunization of DBA/2 mice with a T cell hybridoma-derived TsF increases immune resistance to the syngeneic tumors P815 and L1210. Steele JK, Singhai R, Stammers AT, Levy JG. J Immunol; 1986 Nov 01; 137(9):3025-30. PubMed ID: 3489783 [Abstract] [Full Text] [Related]
16. Potentiation of L1210 murine leukemia vaccine in vivo by levamisole. Kataoka T, Tsukagoshi S, Sakurai Y, Okabe M. Gan; 1979 Aug 01; 70(4):515-9. PubMed ID: 510850 [Abstract] [Full Text] [Related]
17. Promotion of murine antitumor activity by prothymosin alpha treatment: I. Induction of tumoricidal peritoneal cells producing high levels of tumour necrosis factor alpha. Papanastasiou M, Baxevanis CN, Papamichail M. Cancer Immunol Immunother; 1992 Aug 01; 35(2):145-50. PubMed ID: 1596938 [Abstract] [Full Text] [Related]
18. Enhanced induction of immune resistance by concanavalin A-bound L1210 vaccine and an immunopotentiator prepared from Coriolus versicolor. Kataoka T, Oh-hashi F, Tsukagoshi S, Sakurai Y. Cancer Res; 1977 Dec 01; 37(12):4416-9. PubMed ID: 922733 [Abstract] [Full Text] [Related]
19. Development of host-dependent high-grade tumor-specific immunity through a novel mechanism triggered by the Lyt-2+ tumor-specific T cell clone (K7L) that induces temporal growth of L1210 leukemia-K7L-variant. Nagase F, Ueda K, Kawashima K, Jamshedur Rahman SM, Isobe K, Yoshida T, Hasegawa Y, Ando K, Iwamoto T, Nagura E. J Immunol; 1987 Apr 01; 138(7):2359-65. PubMed ID: 2951438 [Abstract] [Full Text] [Related]
20. Intensification of antitumor-immunity by protein-bound polysaccharide, EA6, derived from Flammulina velutipes (Curt. ex Fr.) Sing. combined with murine leukemia L1210 vaccine in animal experiments. Otagiri K, Ohkuma T, Ikekawa T, Tanaka S. J Pharmacobiodyn; 1983 Feb 01; 6(2):96-104. PubMed ID: 6683307 [Abstract] [Full Text] [Related] Page: [Next] [New Search]